> top > docs > PubMed:25345840 > annotations

PubMed:25345840 JSONTXT

Annnotations TAB JSON ListView MergeView

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 325-341 HP_0002721 denotes immunodeficiency
T2 365-381 HP_0100726 denotes Kaposi's sarcoma
T3 374-381 HP_0100242 denotes sarcoma

wangzhuo19_800

Id Subject Object Predicate Lexical cue
T1 14-25 CI denotes bevacizumab
T2 223-234 CI denotes bevacizumab
T3 690-701 CI denotes bevacizumab
T4 977-988 CI denotes bevacizumab
T5 1613-1624 CI denotes bevacizumab
T6 1768-1779 CI denotes bevacizumab
T7 83-99 DP denotes Kaposi's sarcoma
T8 365-381 DP denotes Kaposi's sarcoma
T9 910-926 DP denotes Kaposi's sarcoma
T10 1844-1860 DP denotes Kaposi's sarcoma
T11 528-544 DP denotes Kaposi's sarcoma

Linmchun_800_3

Id Subject Object Predicate Lexical cue
T1 977-988 CI denotes bevacizumab
T10 365-381 DP denotes Kaposi's sarcoma
T11 528-544 DP denotes Kaposi's sarcoma
T12 1844-1860 DP denotes Kaposi's sarcoma
T13 43-71 DP denotes human immunodeficiency virus
T14 349-352 DP denotes HIV
T15 501-504 DP denotes HIV
T16 1872-1875 DP denotes HIV
T3 14-25 CI denotes bevacizumab
T4 223-234 CI denotes bevacizumab
T5 690-701 CI denotes bevacizumab
T6 1613-1624 CI denotes bevacizumab
T7 1768-1779 CI denotes bevacizumab
T8 910-926 DP denotes Kaposi's sarcoma
T9 83-99 DP denotes Kaposi's sarcoma
T17 319-347 DP denotes human immunodeficiency virus

luoyt2021_800_3

Id Subject Object Predicate Lexical cue
T1 14-25 CI denotes bevacizumab
T10 501-504 DP denotes HIV
T11 1844-1860 DP denotes Kaposi's sarcoma
T12 910-926 DP denotes Kaposi's sarcoma
T13 528-544 DP denotes Kaposi's sarcoma
T15 365-381 DP denotes Kaposi's sarcoma
T16 83-99 DP denotes Kaposi's sarcoma
T2 1768-1779 CI denotes bevacizumab
T3 1613-1624 CI denotes bevacizumab
T4 977-988 CI denotes bevacizumab
T5 690-701 CI denotes bevacizumab
T6 223-234 CI denotes bevacizumab
T7 319-347 DP denotes human immunodeficiency virus
T8 349-352 DP denotes HIV
T9 1872-1875 DP denotes HIV
T17 43-71 DP denotes human immunodeficiency virus